A Novel Brain-based Computational Model Of How Parkinson’s Disease And Dopamine Medications Affect Learning And Attention
A new brain-based computational model is helping to understand how Parkinson’s disease and dopamine medications – used to treat motor symptoms caused by the disease – can affect learning and attention. As reported in a forthcoming article in the Journal of Cognitive Neuroscience, a new computational model, at the Center for Molecular and Behavioral Neuroscience at Rutgers University, Newark, has shown how Parkinson’s disease affects attentional performance during learning.
For the full story, Click Here
- GlaxoSmithKline launches new treatment for Parkinson’s disease
- Parkinson’s May Improve Through Brain Device
- OTC cold and cough medicines responsible for ER visits
- FDA reaffirms Shire exclusivity on attention-deficit-hyperactivity disorder drug
